QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio

2026-02-16 - 07:39

Agreement adds new analyzer platforms and expands assay menu across key international markets SAN DIEGO, Feb. 16, 2026 /PRNewswire/ — QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to expand QuidelOrtho’s global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient